Wells Fargo’s Enveric Biosciences ENVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2 | Hold |
2
| – | – | ﹤0.01% | 6594 |
|
|
2025
Q1 | $3 | Sell |
2
-14
| -88% | -$21 | ﹤0.01% | 6448 |
|
|
2024
Q4 | $6 | Hold |
16
| – | – | ﹤0.01% | 6377 |
|
|
2024
Q3 | $8 | Hold |
16
| – | – | ﹤0.01% | 6292 |
|
|
2024
Q2 | $10 | Sell |
16
-21
| -57% | -$13 | ﹤0.01% | 6247 |
|
|
2024
Q1 | $37 | Buy |
37
+4
| +12% | +$4 | ﹤0.01% | 6519 |
|
|
2023
Q4 | $43 | Sell |
33
-1
| -3% | -$1 | ﹤0.01% | 6519 |
|
|
2023
Q3 | $81 | Buy |
34
+4
| +13% | +$10 | ﹤0.01% | 6441 |
|
|
2023
Q2 | $101 | Buy |
30
+1
| +3% | +$3 | ﹤0.01% | 6550 |
|
|
2023
Q1 | $49 | Hold |
29
| – | – | ﹤0.01% | 6792 |
|
|
2022
Q4 | $60 | Buy |
29
+2
| +7% | +$4 | ﹤0.01% | 6623 |
|
|
2022
Q3 | $0 | Sell |
27
-1,093
| -98% | – | ﹤0.01% | 6487 |
|
|
2022
Q2 | $0 | Buy |
1,120
+148
| +15% | – | ﹤0.01% | 6654 |
|
|
2022
Q1 | $0 | Buy |
972
+68
| +8% | – | ﹤0.01% | 6791 |
|
|
2021
Q4 | $1K | Hold |
904
| – | – | ﹤0.01% | 6434 |
|
|
2021
Q3 | $2K | Sell |
904
-4,792
| -84% | -$10.6K | ﹤0.01% | 6230 |
|
|
2021
Q2 | $14K | Buy |
5,696
+4,813
| +545% | +$11.8K | ﹤0.01% | 5700 |
|
|
2021
Q1 | $2K | Buy |
883
+870
| +6,692% | +$1.97K | ﹤0.01% | 6261 |
|
|
2020
Q4 | $0 | Sell |
13
-8
| -38% | – | ﹤0.01% | 6221 |
|
|
2020
Q3 | $0 | Buy |
21
+8
| +62% | – | ﹤0.01% | 6053 |
|
|
2020
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 5986 |
|
|
2020
Q1 | $0 | Buy |
+13
| New | – | ﹤0.01% | 5953 |
|
|
2018
Q1 | – | Sell |
-10,000
| Closed | -$31K | – | 5920 |
|
|
2017
Q4 | $31K | Buy |
+10,000
| New | +$31K | ﹤0.01% | 5358 |
|